Logo image of JEN.DE

JENOPTIK AG (JEN.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:JEN - DE000A2NB601 - Common Stock

18.885 EUR
-0.34 (-1.79%)
Last: 12/10/2025, 5:29:47 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to JEN. JEN was compared to 51 industry peers in the Electronic Equipment, Instruments & Components industry. JEN has only an average score on both its financial health and profitability. JEN is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

JEN had positive earnings in the past year.
JEN had a positive operating cash flow in the past year.
Each year in the past 5 years JEN has been profitable.
In the past 5 years JEN always reported a positive cash flow from operatings.
JEN.DE Yearly Net Income VS EBIT VS OCF VS FCFJEN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1.2 Ratios

JEN has a Return On Assets of 4.37%. This is in the better half of the industry: JEN outperforms 70.59% of its industry peers.
JEN has a better Return On Equity (7.45%) than 66.67% of its industry peers.
JEN has a better Return On Invested Capital (6.01%) than 68.63% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for JEN is in line with the industry average of 7.59%.
Industry RankSector Rank
ROA 4.37%
ROE 7.45%
ROIC 6.01%
ROA(3y)4.32%
ROA(5y)4.15%
ROE(3y)8.12%
ROE(5y)8.24%
ROIC(3y)7.15%
ROIC(5y)6.58%
JEN.DE Yearly ROA, ROE, ROICJEN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

1.3 Margins

JEN has a Profit Margin of 6.89%. This is in the better half of the industry: JEN outperforms 74.51% of its industry peers.
JEN's Profit Margin has been stable in the last couple of years.
JEN has a better Operating Margin (10.91%) than 82.35% of its industry peers.
In the last couple of years the Operating Margin of JEN has grown nicely.
With a Gross Margin value of 31.95%, JEN is not doing good in the industry: 70.59% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of JEN has remained more or less at the same level.
Industry RankSector Rank
OM 10.91%
PM (TTM) 6.89%
GM 31.95%
OM growth 3Y-1.94%
OM growth 5Y5.73%
PM growth 3Y-8.73%
PM growth 5Y0.97%
GM growth 3Y0.54%
GM growth 5Y0.38%
JEN.DE Yearly Profit, Operating, Gross MarginsJEN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), JEN is creating some value.
JEN has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for JEN remains at a similar level compared to 5 years ago.
The debt/assets ratio for JEN has been reduced compared to a year ago.
JEN.DE Yearly Shares OutstandingJEN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
JEN.DE Yearly Total Debt VS Total AssetsJEN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 2.50 indicates that JEN is not a great score, but indicates only limited risk for bankruptcy at the moment.
JEN has a Altman-Z score (2.50) which is in line with its industry peers.
The Debt to FCF ratio of JEN is 4.56, which is a neutral value as it means it would take JEN, 4.56 years of fcf income to pay off all of its debts.
JEN has a Debt to FCF ratio (4.56) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.30 indicates that JEN is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.30, JEN is in line with its industry, outperforming 56.86% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 4.56
Altman-Z 2.5
ROIC/WACC1.01
WACC5.95%
JEN.DE Yearly LT Debt VS Equity VS FCFJEN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

JEN has a Current Ratio of 1.56. This is a normal value and indicates that JEN is financially healthy and should not expect problems in meeting its short term obligations.
JEN has a Current ratio of 1.56. This is comparable to the rest of the industry: JEN outperforms 41.18% of its industry peers.
A Quick Ratio of 0.78 indicates that JEN may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.78, JEN is doing worse than 80.39% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 0.78
JEN.DE Yearly Current Assets VS Current LiabilitesJEN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

JEN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.86%.
The Earnings Per Share has been growing slightly by 6.54% on average over the past years.
Looking at the last year, JEN shows a decrease in Revenue. The Revenue has decreased by -5.27% in the last year.
JEN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.46% yearly.
EPS 1Y (TTM)-14.86%
EPS 3Y4.03%
EPS 5Y6.54%
EPS Q2Q%-19.57%
Revenue 1Y (TTM)-5.27%
Revenue growth 3Y14.12%
Revenue growth 5Y5.46%
Sales Q2Q%-7.1%

3.2 Future

JEN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.51% yearly.
JEN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.76% yearly.
EPS Next Y-17.94%
EPS Next 2Y2.97%
EPS Next 3Y7.39%
EPS Next 5Y7.51%
Revenue Next Year-5.05%
Revenue Next 2Y0.71%
Revenue Next 3Y2.53%
Revenue Next 5Y3.76%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
JEN.DE Yearly Revenue VS EstimatesJEN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B
JEN.DE Yearly EPS VS EstimatesJEN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 14.99, the valuation of JEN can be described as correct.
82.35% of the companies in the same industry are more expensive than JEN, based on the Price/Earnings ratio.
JEN is valuated rather cheaply when we compare the Price/Earnings ratio to 26.59, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 10.99, which indicates a very decent valuation of JEN.
70.59% of the companies in the same industry are more expensive than JEN, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.80, JEN is valued rather cheaply.
Industry RankSector Rank
PE 14.99
Fwd PE 10.99
JEN.DE Price Earnings VS Forward Price EarningsJEN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

74.51% of the companies in the same industry are more expensive than JEN, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of JEN indicates a somewhat cheap valuation: JEN is cheaper than 66.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 11.74
EV/EBITDA 7.54
JEN.DE Per share dataJEN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The decent profitability rating of JEN may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.29
EPS Next 2Y2.97%
EPS Next 3Y7.39%

4

5. Dividend

5.1 Amount

JEN has a Yearly Dividend Yield of 1.97%. Purely for dividend investing, there may be better candidates out there.
JEN's Dividend Yield is a higher than the industry average which is at 2.80.
Compared to an average S&P500 Dividend Yield of 2.31, JEN has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.97%

5.2 History

Dividend Growth(5Y)0%
Div Incr Years0
Div Non Decr Years0
JEN.DE Yearly Dividends per shareJEN.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2025 0.1 0.2 0.3

5.3 Sustainability

29.95% of the earnings are spent on dividend by JEN. This is a low number and sustainable payout ratio.
DP29.95%
EPS Next 2Y2.97%
EPS Next 3Y7.39%
JEN.DE Yearly Income VS Free CF VS DividendJEN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
JEN.DE Dividend Payout.JEN.DE Dividend Payout, showing the Payout Ratio.JEN.DE Dividend Payout.PayoutRetained Earnings

JENOPTIK AG

FRA:JEN (12/10/2025, 5:29:47 PM)

18.885

-0.34 (-1.79%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-12 2025-11-12/bmo
Earnings (Next)03-23 2026-03-23/amc
Inst Owners44.66%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.08B
Revenue(TTM)1.05B
Net Income(TTM)72.61M
Analysts81.25
Price Target25.2 (33.44%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.97%
Yearly Dividend0.35
Dividend Growth(5Y)0%
DP29.95%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.92%
Min EPS beat(2)-7.96%
Max EPS beat(2)-5.88%
EPS beat(4)1
Avg EPS beat(4)-7.55%
Min EPS beat(4)-20.99%
Max EPS beat(4)4.63%
EPS beat(8)3
Avg EPS beat(8)-5.97%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.26%
Min Revenue beat(2)-5.74%
Max Revenue beat(2)-2.79%
Revenue beat(4)0
Avg Revenue beat(4)-3.45%
Min Revenue beat(4)-5.74%
Max Revenue beat(4)-1.93%
Revenue beat(8)1
Avg Revenue beat(8)-6.46%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.46%
PT rev (3m)0.35%
EPS NQ rev (1m)1.12%
EPS NQ rev (3m)1.12%
EPS NY rev (1m)2.26%
EPS NY rev (3m)-1.63%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.46%
Revenue NY rev (3m)-1.11%
Valuation
Industry RankSector Rank
PE 14.99
Fwd PE 10.99
P/S 1.03
P/FCF 11.74
P/OCF 6.15
P/B 1.11
P/tB 3.57
EV/EBITDA 7.54
EPS(TTM)1.26
EY6.67%
EPS(NY)1.72
Fwd EY9.1%
FCF(TTM)1.61
FCFY8.52%
OCF(TTM)3.07
OCFY16.27%
SpS18.41
BVpS17.03
TBVpS5.29
PEG (NY)N/A
PEG (5Y)2.29
Graham Number21.97
Profitability
Industry RankSector Rank
ROA 4.37%
ROE 7.45%
ROCE 8.76%
ROIC 6.01%
ROICexc 6.3%
ROICexgc 13.58%
OM 10.91%
PM (TTM) 6.89%
GM 31.95%
FCFM 8.73%
ROA(3y)4.32%
ROA(5y)4.15%
ROE(3y)8.12%
ROE(5y)8.24%
ROIC(3y)7.15%
ROIC(5y)6.58%
ROICexc(3y)7.54%
ROICexc(5y)6.96%
ROICexgc(3y)16.1%
ROICexgc(5y)15.71%
ROCE(3y)10.41%
ROCE(5y)9.58%
ROICexgc growth 3Y-2.02%
ROICexgc growth 5Y2.07%
ROICexc growth 3Y7.18%
ROICexc growth 5Y-3.9%
OM growth 3Y-1.94%
OM growth 5Y5.73%
PM growth 3Y-8.73%
PM growth 5Y0.97%
GM growth 3Y0.54%
GM growth 5Y0.38%
F-Score4
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 4.56
Debt/EBITDA 1.51
Cap/Depr 107.82%
Cap/Sales 7.96%
Interest Coverage 8.16
Cash Conversion 91.27%
Profit Quality 126.78%
Current Ratio 1.56
Quick Ratio 0.78
Altman-Z 2.5
F-Score4
WACC5.95%
ROIC/WACC1.01
Cap/Depr(3y)121.37%
Cap/Depr(5y)106.88%
Cap/Sales(3y)8.22%
Cap/Sales(5y)7.57%
Profit Quality(3y)101.44%
Profit Quality(5y)95.78%
High Growth Momentum
Growth
EPS 1Y (TTM)-14.86%
EPS 3Y4.03%
EPS 5Y6.54%
EPS Q2Q%-19.57%
EPS Next Y-17.94%
EPS Next 2Y2.97%
EPS Next 3Y7.39%
EPS Next 5Y7.51%
Revenue 1Y (TTM)-5.27%
Revenue growth 3Y14.12%
Revenue growth 5Y5.46%
Sales Q2Q%-7.1%
Revenue Next Year-5.05%
Revenue Next 2Y0.71%
Revenue Next 3Y2.53%
Revenue Next 5Y3.76%
EBIT growth 1Y-19.47%
EBIT growth 3Y11.91%
EBIT growth 5Y11.51%
EBIT Next Year33.26%
EBIT Next 3Y19.98%
EBIT Next 5Y14.54%
FCF growth 1Y28.17%
FCF growth 3Y12.68%
FCF growth 5Y2.87%
OCF growth 1Y14.61%
OCF growth 3Y19.51%
OCF growth 5Y8.88%

JENOPTIK AG / JEN.DE FAQ

What is the fundamental rating for JEN stock?

ChartMill assigns a fundamental rating of 5 / 10 to JEN.DE.


Can you provide the valuation status for JENOPTIK AG?

ChartMill assigns a valuation rating of 6 / 10 to JENOPTIK AG (JEN.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for JENOPTIK AG?

JENOPTIK AG (JEN.DE) has a profitability rating of 6 / 10.


What is the financial health of JENOPTIK AG (JEN.DE) stock?

The financial health rating of JENOPTIK AG (JEN.DE) is 4 / 10.


What is the earnings growth outlook for JENOPTIK AG?

The Earnings per Share (EPS) of JENOPTIK AG (JEN.DE) is expected to decline by -17.94% in the next year.